{
    "nctId": "NCT06194565",
    "briefTitle": "99mTc-ABH2 SPECT/CT in Breast Cancer",
    "officialTitle": "Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ABH2 SPECT/CT",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "SPECT/CT-based 99mTc-ABH2 uptake value in tumor lesions",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* clinically suspected primary breast cancer by mammography or ultrasonography and being able to sign the written informed consent form\n\nExclusion Criteria:\n\n* pregnancy or lactation, impaired liver or kidney failure, and undergoing any preceding local or systemic therapies that might interfere HER2 binding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}